Recent data suggest alternative mechanisms that promote HLA-associated drug syndromes.

Abacavir binds within the antigen-binding cleft of human leukocyte antigen (HLA)-B*57:01. Read more about it here.

Read More

Molecular Mountaineers

UF drug development researchers are forging new trails to cancer treatments. Read about it here.

Read More

Drug Discovery

We use methods in structure-based drug design to discover and develop novel therapies for human diseases. We are actively targeting cardiovascular diseases, cancer and diabetes by high-throughput virtual screening combined […]

Read More
Prev Next

Contact Us

Nature ImmunologySubscribe to this RSS Feed

Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

November 13, 2019

Nature Immunology, Published online: 13 November 2019; doi:10.1038/s41590-019-0554-3Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated...

Author Correction: Mechanosensing through immunoreceptors

November 4, 2019

Nature Immunology, Published online: 04 November 2019; doi:10.1038/s41590-019-0545-4Author Correction: Mechanosensing through immunoreceptors

How to wake a killer

October 28, 2019

Nature Immunology, Published online: 28 October 2019; doi:10.1038/s41590-019-0541-8Manipulating the mitochondrial morphology of exhausted tumor-derived NK cells restores their metabolic fitness and...

CAR T cells for heart disease

October 22, 2019

Nature Immunology, Published online: 22 October 2019; doi:10.1038/s41590-019-0536-5CAR T cells for heart disease

Bat adaptive immunity

October 22, 2019

Nature Immunology, Published online: 22 October 2019; doi:10.1038/s41590-019-0533-8Bat adaptive immunity